Literature DB >> 27808441

UHPLC-MS/MS determination and pharmacokinetic study of plantamajoside in rat plasma after oral administration of single plantamajoside and Plantago asiatica extract.

Lizhi Bai1,2, Li Han3, Xiaoguang Lu2, Xin Kang2, Zhiwei Fan2, Rong Xing4, Dangxia Zhou1.   

Abstract

A sensitive and reliable ultra-high performance liquid chromatography coupled with tandem quadrupole mass spectrometry (UHPLC-MS/MS) method was developed for quantitation of plantamajoside in rat plasma. First, this study compared the pharmacokinetic properties of plantamajoside after oral administration of Plantago asiatica extract and pure plantamajoside in rat plasma with approximately the same dosage of 8.98 mg/kg. Second, chromatographic separation was performed on an Acquity HSS C18 column (50 × 2.1 mm, p.d.1.7 μm) with isocratic elution using methanol-water (80:20, v/v) as mobile phase at a flow rate of 0.25 mL/min. The calibration curves were linear over the range of 0.1-100 ng/mL for plantamajoside. At different time points (0, 0.083, 0.167, 0.25, 0.5, 0.75, 1, 2, 3, 4, 5, 6 and 8 h) after administration, the concentrations of plantamajoside in plasma were measured and the main pharmacokinetic parameters were estimated. The study indicates that the pharmacokinetics of plantamajoside in rat plasma have significant differences between two groups.
Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Plantago asiatica extract; UHPLC-MS/MS; comparative pharmacokinetics; plantamajoside; rat plasma

Mesh:

Substances:

Year:  2016        PMID: 27808441     DOI: 10.1002/bmc.3883

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  2 in total

1.  An UPLC-MS/MS Method for Simultaneous Quantification of the Components of Shenyanyihao Oral Solution in Rat Plasma.

Authors:  Chunbo Jiang; Guoqiang Liang; Yan Ren; Tianjun Xu; Yongliang Song; Weimin Jin
Journal:  Biomed Res Int       Date:  2020-08-13       Impact factor: 3.411

2.  Plantamajoside modulates the proliferation, stemness, and apoptosis of lung carcinoma via restraining p38MAPK and AKT phosphorylation.

Authors:  Yazhou Li; Ruiyang Han; Wei Cao
Journal:  Transl Cancer Res       Date:  2020-06       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.